German economic data showed the GDP rose more than expected in Q2
Wall Street ended higher, as the FDA’s full approval of a COVID-19 vaccine and the absence of negative catalysts kept risk appetite alive ahead of the Jackson Hole Symposium. USA30 rose 0.09%, and USA500 gained 0.15%. TECH100 added 0.52%.
Crude oil went up 1.1% at $66.39 a barrel.
Gold rose 0.2% to $1,803.15 per ounce.
Asia and Australia
Stocks were up, boosted by the FDA’s approval of the COVID-19 vaccine, which is expected to increase US vaccination rates and assuage concerns over the virus’s impact on global economic recovery.
Japan225 rose 1.12%.
HongKong45 was up 0.28%.
Down under, Australia200 traded 0.28% higher.
Markets closed in the green, helped by stronger than expected German growth and the full US approval of the Pfizer-BioNTech COVID-19 vaccine.
Brent oil rose 1.2% to $69.19 per barrel.
EUR/USD lost 0.1% trading at 1.1737.
Sources: investing.com, reuters.com
Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.
Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.